Company / Tangible Book Value per Share
AbCellera Biologics Inc. Tangible Book Value per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$3.11
FY2025
5-year range
-$0.08 / $3.85
FY2021-FY2025
Trend
-10.4%
vs FY2024
Sector context
#125 of 209
Health Care
What the data says
At $3.11, AbCellera Biologics Inc.'s tangible book value per share ranks #125 of 209 in the Health Care sector. Tangible Book Value per Share has fluctuated over the past 7 years, ranging from $-0.08 in FY2021 to $3.85 in FY2023.
Based on SEC 10-K filings.
3.11 in FY2025 with a 5-year CAGR of +0.5%.
Declined from $3.85 to $3.11 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +4.0%
- 5-Year CAGR
- +0.5%
- 10-Year CAGR
- -
Sector benchmark
#125 of 209 in Health CareTop 60% of 209This company $3.11 Sector average $119.74
▼
-97.4% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share decreased 10.4% year-over-year.
- Ranks #125 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2023.
- Lowest tangible book value per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.11 | -10.4% |
| FY2024 | $3.47 | -10.0% |
| FY2023 | $3.85 | +39.3% |
| FY2022 | $2.76 | +3604.7% |
| FY2021 | -$0.08 | -102.6% |
| FY2020 | $3.04 | +4382.2% |
| FY2019 | $0.07 | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026